Title |
Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy
|
---|---|
Published in |
Frontiers in immunology, February 2017
|
DOI | 10.3389/fimmu.2017.00071 |
Pubmed ID | |
Authors |
Qi Zhang, Bo Zhu, Yongsheng Li |
Abstract |
Inflammation is a protective response that eliminates harmful stimuli and restores tissue homeostasis, whereas the failure to resolve inflammation leads to the development of malignancies. Immune cells in the tumor inflammatory microenvironment endow cancer cells with their specific hallmarks, including mutations, metabolic reprograming, angiogenesis, invasion, and metastasis. Targeting the inflammatory microenvironment with anti-inflammatory drugs (e.g., aspirin) or by enhancing antitumor immunity (e.g., chimeric antigen receptor T cell therapy) has been extensively investigated and has achieved promising results in many cancers. Recently, a novel approach promoting antitumor immunity via a dual anti-inflammatory and pro-resolving strategy was proposed based on the discovery of potent, endogenous, specialized pro-resolving mediators, including lipoxins, resolvins, protectins, and maresins. In this review, we describe the updated principal cellular and molecular mechanisms of inflammation resolution and cancer immunity and discuss the pro-resolution strategy in cancer treatment and prevention. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 30% |
France | 1 | 10% |
Switzerland | 1 | 10% |
Unknown | 5 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 50% |
Scientists | 3 | 30% |
Practitioners (doctors, other healthcare professionals) | 2 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Sweden | 1 | <1% |
Portugal | 1 | <1% |
Unknown | 167 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 25 | 15% |
Student > Bachelor | 23 | 14% |
Student > Master | 22 | 13% |
Researcher | 18 | 11% |
Student > Doctoral Student | 14 | 8% |
Other | 30 | 18% |
Unknown | 37 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 33 | 20% |
Medicine and Dentistry | 31 | 18% |
Agricultural and Biological Sciences | 21 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 7% |
Chemistry | 7 | 4% |
Other | 17 | 10% |
Unknown | 48 | 28% |